This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Venous thromboembolism

Authoring team

Venous thromboembolism (VTE) is when a thrombus (blood clot) forms in a vein which may dislodge from its site of origin to travel in the blood, an occurrence known as embolism (1).

  • majority of thrombus formation occurs in the deep veins of the leg, hence the most frequent manifestation of VTE is deep venous thrombosis (DVT)
    • almost two thirds of VTE cases are isolated DVTs (2)
  • a dislodged thrombus may travel to the lung and cause pulmonary embolism (PE) (1,3).

It is the third most commonest vascular disease after coronary artery disease and stroke (4).
Incidence of VTE increases sharply with age:

  • women are more often affected at a younger age while in the elderly, this ratio reverses
  • a lower incidence is seen in Asians (2)

VTE is an important cause of death in hospitalised patients (1).

  • all patients admitted to the hospital or presenting acutely to hospital should be individually assessed for risk of VTE and bleeding
  • this assessment should be repeated regularly and at least every 48 hours (5)

Venous thromboembolism (VTE), clinically presenting as DVT or PE, is globally the third most frequent acute cardiovascular syndrome behind myocardial infarction and stroke (6):

  • annual incidence rates for PE range from 39-115 per 100 000 population; for DVT, incidence rates range from 53-162 per 100 000 population
  • cross-sectional data show that the incidence of VTE is almost eight times higher in individuals aged >= 80 years than in the fifth decade of life.

Various risk factors for VTE have been categorised (6)

Strong risk factors (Odds Ratio (OR) > 10)


Fracture of lower limb
Hospitalization for heart failure or atrial fibrillation/flutter
(within previous 3 months)
Hip or knee replacement
Major trauma
Myocardial infarction (within previous 3 months)
Previous VTE
Spinal cord injury

 

 

 

 

 

 

 

Moderate risk factors (OR 2- 9)


Arthroscopic knee surgery
Autoimmune diseases
Blood transfusion
Central venous lines
Intravenous catheters and leads
Chemotherapy
Congestive heart failure or respiratory failure
Erythropoiesis-stimulating agents
Hormone replacement therapy (depends on formulation)
In vitro fertilization
Oral contraceptive therapy
Post-partum period
Infection (specifically pneumonia, urinary tract infection, and HIV)
Inflammatory bowel disease
Cancer (highest risk in metastatic disease)
Paralytic stroke
Superficial vein thrombosis
Thrombophilia

 

Weak risk factors (OR < 2)

Bed rest >3 days
Diabetes mellitus
Arterial hypertension
Immobility due to sitting (e.g. prolonged car or air travel)
Increasing age
Laparoscopic surgery (e.g. cholecystectomy)
Obesity
Pregnancy
Varicose veins

 

 

 

 

 

 

 


HIV = human immunodeficiency virus; OR = odds ratio

References:

  1. NICE. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing. NICE guideline NG158. Published: 26 March 2020. Last updated: 02 August 2023
  2. Mazzolai L et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European society of cardiology working groups of aorta and peripheral circulation and pulmonary circulation and right ventricular function. Eur Heart J. 2017 Feb 17.
  3. Snow V et al. Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2007;146(3):204-10
  4. Douketis JD. Treatment of deep vein thrombosis: what factors determine appropriate treatment? Can Fam Physician. 2005;51:217-23
  5. Scottish Intercollegiate Guidelines Network (SIGN) 2010. Prevention and Management of Venous Thromboembolism.
  6. Konstantinides SV et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019 Oct 9;54(3).

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.